CUR. On Watch. 12-27-2011 FDA - Neuralstem's NSI-189 Trial in Major Depressive Disorder Receives FDA Approval to Advance to Phase Ib http://ih.advfn.com/p.php?pid=nmona&article=50544901 stockcharts.com/c-sc/sc?s=cur&p=d&yr=0&mn=3&dy=0&id=p31855006177